KH321
2021-12-26
OK
2 Meme Stocks to Watch as We Head Into the New Year
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":698414978,"tweetId":"698414978","gmtCreate":1640491350042,"gmtModify":1640491350450,"author":{"id":3586451610703869,"idStr":"3586451610703869","authorId":3586451610703869,"authorIdStr":"3586451610703869","name":"KH321","avatar":"https://static.tigerbbs.com/c1bb8bd7d6d5df5f9732871fe60999ea","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":35,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>OK </p></body></html>","htmlText":"<html><head></head><body><p>OK </p></body></html>","text":"OK","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/698414978","repostId":1191047763,"repostType":4,"repost":{"id":"1191047763","pubTimestamp":1640316276,"share":"https://www.laohu8.com/m/news/1191047763?lang=&edition=full","pubTime":"2021-12-24 11:24","market":"us","language":"en","title":"2 Meme Stocks to Watch as We Head Into the New Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1191047763","media":"TheStreet","summary":"With an eye on momentum catalysts, short interest, and popularity, we picked two meme stocks that ar","content":"<p>With an eye on momentum catalysts, short interest, and popularity, we picked two meme stocks that are worth watching through at least the end of 2021.</p>\n<p>Trading meme stocks is a high-risk high-reward proposition, as it’s quite difficult to know when momentum starts and ends. Monitoring major discussion forums to identify potential highflyers is a strategy that can sometimes yield impressive results.</p>\n<p>With a focus on stocks’ popularity, elevated short interest, and imminent broad market catalysts, we’ve landed on two “meme” stocks to watch until at least New Year’s Eve: Vinco Venturers(<b>BBIG</b>) and Ocugen(<b>OCGN</b>).</p>\n<p><b>#1. Vinco Ventures — $BBIG</b></p>\n<p>Fairport, NY-based Vinco Ventures (<b>BBIG</b>) operates thirteen consumer and digital marketing brands, including The 911 Help Now, Global Clean Solution, and Ferguson Containers. The company’s business model is based on “aggressive acquisitions.” Shares are up nearly 25% since early December – most of this rise may stem from Vinco Ventures’ deal to sell warrants to an institutional investor.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d05f11666ed8980eeea9a8a0e1d9c55b\" tg-width=\"1240\" tg-height=\"649\" width=\"100%\" height=\"auto\"><span>Figure 1: Vinco Ventures logo.</span></p>\n<p>Looking a bit further back, in September, Vinco Ventures announced a joint venture with Zash Global Media to acquire Lomotif, a TikTok-style social media platform that is very popular in India. Lomotif, through its subsidiary Emmersive Entertainment, also recently launched a platform for music streaming and NFT’s.</p>\n<p>After the acquisition announcement, Vinco Ventures stock’s popularity started skyrocketing on popular discussion boards, and the stock’s price grew a whopping 268% over ten trading days, from August 26 to September 9.</p>\n<p>Another catalyst for BBIG’s astronomical rise is that the company has been the target of many short sellers; roughly 20% of the company's float is currently shorted.</p>\n<p>A combination of these factors lead to BBIG becoming a meme stock, and it continues to trend in discussions on major Reddit forums (see below).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6252e41f7120ba24f611dc9bfbb55353\" tg-width=\"1070\" tg-height=\"703\" width=\"100%\" height=\"auto\"><span>Figure 2: Trending stocks on Reddit on December 22.</span></p>\n<p><b>#2. Ocugen — $OCGN</b></p>\n<p>Biopharmaceutical company Ocugen, which focuses mainly on gene therapies to cure diseases that cause blindness, has had its ticker trend multiple times since the beginning of October.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ec6ec1b0cb2ede3b048b87c4dd0d90f6\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 3: Ocugen holds the rights to commercialize Covaxin COVID-19 vaccine in North America.</span></p>\n<p>The company has become a meme focus, even though it is currently 70% off its early-November peaks. The most likely catalyst behind the price surge is the anticipated World Health Organization’s approval of a COVID-19 vaccine called Covaxin.</p>\n<p>Ocugen is a co-development partner with Bharat Biotech on the vaccine, and it holds the rights to commercialize Covaxin in North America.Stage-3 results showed the drug to be efficient against the Delta variant, which will be helpful during the approval process.</p>\n<p>However, the vaccine’s efficacy against the Omicron variant is still a big unknown. Ocugen plans on releasing its own study on the vaccine’s efficiency against the new variant as soon as the work has been completed.</p>\n<p>Meanwhile, the stock remains a bear target. OCGN has 56 million shares shorted, representing a whopping 25% of the float. While heavy shorting signals skepticism and caution, it can also set up shares for a short squeeze, which could be triggered by massive buy volumes.</p>\n<p>Eventual vaccine approval and a proven efficiency against the Omicron variant could be the catalyst that sparks just that type of bullish short-term activity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Meme Stocks to Watch as We Head Into the New Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Meme Stocks to Watch as We Head Into the New Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 11:24 GMT+8 <a href=https://www.thestreet.com/memestocks/other-memes/2-meme-stocks-to-watch-as-we-head-into-the-new-year><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With an eye on momentum catalysts, short interest, and popularity, we picked two meme stocks that are worth watching through at least the end of 2021.\nTrading meme stocks is a high-risk high-reward ...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/other-memes/2-meme-stocks-to-watch-as-we-head-into-the-new-year\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BBIG":"Vinco Ventures, Inc.","OCGN":"Ocugen"},"source_url":"https://www.thestreet.com/memestocks/other-memes/2-meme-stocks-to-watch-as-we-head-into-the-new-year","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191047763","content_text":"With an eye on momentum catalysts, short interest, and popularity, we picked two meme stocks that are worth watching through at least the end of 2021.\nTrading meme stocks is a high-risk high-reward proposition, as it’s quite difficult to know when momentum starts and ends. Monitoring major discussion forums to identify potential highflyers is a strategy that can sometimes yield impressive results.\nWith a focus on stocks’ popularity, elevated short interest, and imminent broad market catalysts, we’ve landed on two “meme” stocks to watch until at least New Year’s Eve: Vinco Venturers(BBIG) and Ocugen(OCGN).\n#1. Vinco Ventures — $BBIG\nFairport, NY-based Vinco Ventures (BBIG) operates thirteen consumer and digital marketing brands, including The 911 Help Now, Global Clean Solution, and Ferguson Containers. The company’s business model is based on “aggressive acquisitions.” Shares are up nearly 25% since early December – most of this rise may stem from Vinco Ventures’ deal to sell warrants to an institutional investor.\nFigure 1: Vinco Ventures logo.\nLooking a bit further back, in September, Vinco Ventures announced a joint venture with Zash Global Media to acquire Lomotif, a TikTok-style social media platform that is very popular in India. Lomotif, through its subsidiary Emmersive Entertainment, also recently launched a platform for music streaming and NFT’s.\nAfter the acquisition announcement, Vinco Ventures stock’s popularity started skyrocketing on popular discussion boards, and the stock’s price grew a whopping 268% over ten trading days, from August 26 to September 9.\nAnother catalyst for BBIG’s astronomical rise is that the company has been the target of many short sellers; roughly 20% of the company's float is currently shorted.\nA combination of these factors lead to BBIG becoming a meme stock, and it continues to trend in discussions on major Reddit forums (see below).\nFigure 2: Trending stocks on Reddit on December 22.\n#2. Ocugen — $OCGN\nBiopharmaceutical company Ocugen, which focuses mainly on gene therapies to cure diseases that cause blindness, has had its ticker trend multiple times since the beginning of October.\nFigure 3: Ocugen holds the rights to commercialize Covaxin COVID-19 vaccine in North America.\nThe company has become a meme focus, even though it is currently 70% off its early-November peaks. The most likely catalyst behind the price surge is the anticipated World Health Organization’s approval of a COVID-19 vaccine called Covaxin.\nOcugen is a co-development partner with Bharat Biotech on the vaccine, and it holds the rights to commercialize Covaxin in North America.Stage-3 results showed the drug to be efficient against the Delta variant, which will be helpful during the approval process.\nHowever, the vaccine’s efficacy against the Omicron variant is still a big unknown. Ocugen plans on releasing its own study on the vaccine’s efficiency against the new variant as soon as the work has been completed.\nMeanwhile, the stock remains a bear target. OCGN has 56 million shares shorted, representing a whopping 25% of the float. While heavy shorting signals skepticism and caution, it can also set up shares for a short squeeze, which could be triggered by massive buy volumes.\nEventual vaccine approval and a proven efficiency against the Omicron variant could be the catalyst that sparks just that type of bullish short-term activity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1022,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/698414978"}
精彩评论